• Pioneering endosomal escape through rationally designed peptide shuttles, enabling efficient delivery of small molecules, proteins, enzymes and oligonucleotides across diverse cell types
• Delivering functional biomolecules in different animal models
• Demonstrating clinical potential of the Feldan technology through in vivo data and progression to first-in-human trial for basal cell carcinoma

NEW COMPANY